Kang HJ - Search Results

1

Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era.

Choi S, Kim BK, Ahn HY, Hong KT, Choi JY, Shin HY, Kang HJ. Choi S, et al. Among authors: kang hj. Blood Res. 2020 Dec 31;55(4):217-224. doi: 10.5045/br.2020.2020127. Blood Res. 2020. PMID: 33232940 Free PMC article.

2

Acute leukemias with unusual immunophenotypes.

Park MH, Yang YS, Cho HI, Kim BK, Park S, Ahn HS, Shin HY, Kang HJ, Oh WI, Kim SI. Park MH, et al. Among authors: kang hj. J Korean Med Sci. 1992 Dec;7(4):377-84. doi: 10.3346/jkms.1992.7.4.377. J Korean Med Sci. 1992. PMID: 1299244 Free PMC article.

3

Transient spontaneous remission in acute promyelocytic leukemia--two case reports.

Kang HJ, Yoon JH, Cho HI, Kim BK, Kim SI. Kang HJ, et al. J Korean Med Sci. 1993 Apr;8(2):166-70. doi: 10.3346/jkms.1993.8.2.166. J Korean Med Sci. 1993. PMID: 8397934 Free PMC article.

4

Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML).

Kang HJ, Shin HY, Choi HS, Ahn HS. Kang HJ, et al. Leuk Res. 2004 Feb;28(2):167-70. doi: 10.1016/s0145-2126(03)00217-0. Leuk Res. 2004. PMID: 14654081 Clinical Trial.

5

Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia.

Kang HJ, Shin HY, Choi HS, Han KS, Ahn HS. Kang HJ, et al. Bone Marrow Transplant. 2004 Mar;33(5):471-6. doi: 10.1038/sj.bmt.1704389. Bone Marrow Transplant. 2004. PMID: 14716339 Clinical Trial.

6

Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.

Kang HJ, Shin HY, Choi HS, Ahn HS. Kang HJ, et al. Bone Marrow Transplant. 2004 Dec;34(11):939-43. doi: 10.1038/sj.bmt.1704720. Bone Marrow Transplant. 2004. PMID: 15489866

7

In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method.

Ryu KH, Cho SJ, Jung YJ, Seoh JY, Kie JH, Koh SH, Kang HJ, Ahn HS, Shin HY. Ryu KH, et al. Among authors: kang hj. Int J Hematol. 2004 Oct;80(3):281-6. doi: 10.1532/ijh97.a10406. Int J Hematol. 2004. PMID: 15540905

8

Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death.

Koh SH, Choi HS, Park ES, Kang HJ, Ahn HS, Shin HY. Koh SH, et al. Among authors: kang hj. Biochem Biophys Res Commun. 2005 Apr 15;329(3):1039-45. doi: 10.1016/j.bbrc.2005.02.077. Biochem Biophys Res Commun. 2005. PMID: 15752760

9

Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.

Kang HJ, Hong SH, Kim IH, Park BK, Han KS, Cho HI, Shin HY, Ahn HS. Kang HJ, et al. Leuk Res. 2005 Jun;29(6):617-23. doi: 10.1016/j.leukres.2004.11.006. Epub 2005 Jan 21. Leuk Res. 2005. PMID: 15863200

10

Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.

Shin HY, Kang HJ, Park ES, Choi HS, Ahn HS, Kim SY, Chung NG, Kim HK, Kim SY, Kook H, Hwang TJ, Lee KC, Lee SM, Lee KS, Yoo KH, Koo HH, Lee MJ, Seo JJ, Moon HN, Ghim T, Lyu CJ, Lee WS, Choi YM. Shin HY, et al. Among authors: kang hj. Pediatr Blood Cancer. 2006 Apr;46(4):439-45. doi: 10.1002/pbc.20555. Pediatr Blood Cancer. 2006. PMID: 16123985 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,442 results

Search Page